April 22, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 2,022 shares of Abrdn Life Sciences Investors at $12.88 per share, a transaction worth $26.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.